Antituberculous therapy and acute liver function.
作者信息
Ong E L
出版信息
Lancet. 1995 May 6;345(8958):1171.
PMID:7723557
Abstract
摘要
相似文献
1
Antituberculous therapy and acute liver function.抗结核治疗与急性肝功能
Lancet. 1995 May 6;345(8958):1171.
2
Antituberculous therapy and acute liver function.抗结核治疗与急性肝功能
Lancet. 1995 May 6;345(8958):1171-2.
3
4
6
[Therapy of tuberculosis in the adult].[成人肺结核的治疗]
Med Klin (Munich). 1995 Apr 15;90(4):229-30.
7
Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council.对痰涂片阳性肺结核患者采用每周三次、为期6个月的治疗方案，比较2个月、4个月和6个月吡嗪酰胺使用时间的对照试验，包括对异烟肼、利福平及吡嗪酰胺复方制剂的评估。30个月时的结果。香港胸科服务处/英国医学研究委员会
Am Rev Respir Dis. 1991 Apr;143(4 Pt 1):700-6. doi: 10.1164/ajrccm/143.4_Pt_1.700.
8
[Short term chemotherapy of tuberculosis. Evaluation of an 18-week-long treatment including pyrazinamide (preliminary results)].[结核病的短期化疗。对含吡嗪酰胺的18周治疗方案的评估（初步结果）]
Bull Int Union Tuberc. 1978 Dec;53(4):260-1.
9
Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.在一项针对涂片阳性肺结核的三种6个月治疗方案的对照试验中，对异烟肼、利福平及吡嗪酰胺每日联合制剂的评估。新加坡结核病防治所/英国医学研究委员会
Am Rev Respir Dis. 1991 Apr;143(4 Pt 1):707-12. doi: 10.1164/ajrccm/143.4_Pt_1.707.
10
Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis.六个月和四个月化疗方案治疗肺结核的临床试验
Am Rev Respir Dis. 1979 Apr;119(4):579-85. doi: 10.1164/arrd.1979.119.4.579.
Zotero 插件